SION 8-K: SEC filing

Sionna Therapeutics

Filed with the SEC on · accession 0001628280-26-072497

SION filed a 8-K (current report) with the SEC on Nov 10, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Summary of the filing

Sionna Therapeutics issued a press release announcing its financial results and business highlights for the quarter ended September 30, 2026, furnished under Item 2.02 of Form 8-K.

Key details

RegistrantSionna Therapeutics, Inc.
Chief legal officer and head of program managementJennifer Fitzpatrick

✦ Ask GOAX AI about this filing — what it means for SION, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for SION?

Click here

Frequently asked questions

What did SION file with the SEC on Nov 10, 2026?

SION filed a 8-K (SEC filing). Sionna Therapeutics issued a press release announcing its financial results and business highlights for the quarter ended September 30, 2026, furnished under Item 2.02 of Form 8-K.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other SION SEC filings

Get alerts when SION files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days